home.social

#siopen — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #siopen, aggregated by home.social.

  1. Yesterday, me and my colleague took the #NightTrain to #Vienna, to join the #SIOPEN #translational research meeting.

    Little under 10 hours from Utrecht.

    I had to present our latest work on
    #neuroblastoma. Beers to celebrate this event. 🍻

    #train #NightJet
    #PedriaticCancer
    #NoFlying

  2. Yesterday, me and my colleague took the #NightTrain to #Vienna, to join the #SIOPEN #translational research meeting.

    Little under 10 hours from Utrecht.

    I had to present our latest work on
    #neuroblastoma. Beers to celebrate this event. 🍻

    #train #NightJet
    #PedriaticCancer
    #NoFlying

  3. Yesterday, me and my colleague took the #NightTrain to #Vienna, to join the #SIOPEN #translational research meeting.

    Little under 10 hours from Utrecht.

    I had to present our latest work on
    #neuroblastoma. Beers to celebrate this event. 🍻

    #train #NightJet
    #PedriaticCancer
    #NoFlying

  4. Yesterday, me and my colleague took the #NightTrain to #Vienna, to join the #SIOPEN #translational research meeting.

    Little under 10 hours from Utrecht.

    I had to present our latest work on
    #neuroblastoma. Beers to celebrate this event. 🍻

    #train #NightJet
    #PedriaticCancer
    #NoFlying

  5. Yesterday, me and my colleague took the #NightTrain to #Vienna, to join the #SIOPEN #translational research meeting.

    Little under 10 hours from Utrecht.

    I had to present our latest work on
    #neuroblastoma. Beers to celebrate this event. 🍻

    #train #NightJet
    #PedriaticCancer
    #NoFlying

  6. Important work, the #ITCC #SIOPEN #BEACON #neuroblastoma #trial

    ascopubs.org/doi/10.1200/JCO.2

    In this trial Moreno et al. assessed possible added effects of #antiangiogenic agent #bevacizumab to #temozolomide treatment plus or minus #irinotecan or #topotecan for children with relapsed and refractory neuroblastoma.

    Perhaps some early effects, but after 5-6 years rather depressing survival graphs, if I'm very honest.

    #CancerResearch